Source Date | Board Meeting Date | Details |
28-Oct-2024
|
06-Nov-2024
|
Quarterly Results
|
23-Jul-2024
|
31-Jul-2024
|
Quarterly Results & Audited Results
|
23-May-2024
|
29-May-2024
|
Final Dividend & Audited Results & Quarterly Results & Inter alia will also consider the issuance of unsecured Non-Convertible Debentures on private placement basis.
|
14-Mar-2024
|
19-Mar-2024
|
Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis.
|
16-Jan-2024
|
24-Jan-2024
|
Quarterly Results
|
25-Oct-2023
|
01-Nov-2023
|
Quarterly Results
|
14-Jul-2023
|
24-Jul-2023
|
Quarterly Results
|
17-Apr-2023
|
02-May-2023
|
Final Dividend & Audited Results
|
15-Feb-2023
|
20-Feb-2023
|
Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis, within the limits approved by the Board of Directors of the Company at its meetings held on August 13, 2018 and April 24, 2020.
|
12-Jan-2023
|
06-Feb-2023
|
Quarterly Results
|
20-Oct-2022
|
31-Oct-2022
|
Quarterly Results
|
09-Sep-2022
|
14-Sep-2022
|
Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis, within the limits approved by the Board of Directors at their meetings held on August 13, 2018 and April 24, 2020.
|
15-Jul-2022
|
25-Jul-2022
|
Quarterly Results
|
18-Apr-2022
|
03-May-2022
|
Stock Split & Final Dividend & Audited Results Inter alia: 1. to consider and take on record the audited Standalone and unaudited Consolidated financial statements and results for the quarter ended March 31, 2022; 2. to consider and take on record the audited Standalone and Consolidated financial statements and results for the financial year ended March 31, 2022; 3. recommend dividend, if any, for the financial year ended March 31, 2022; and 4. to consider a proposal for sub-division of the Equity shares of the Company having a face value of ?10/- each, in such manner as may be determined by the Board of Directors, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company.
|
28-Jan-2022
|
04-Feb-2022
|
Quarterly Results
|
01-Nov-2021
|
11-Nov-2021
|
Quarterly Results
|
04-Aug-2021
|
12-Aug-2021
|
Quarterly Results
|
29-Apr-2021
|
05-May-2021
|
Final Dividend & Audited Results
|
02-Feb-2021
|
09-Feb-2021
|
Quarterly Results
|
06-Nov-2020
|
13-Nov-2020
|
Quarterly Results
|